Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Goodwill & Intangibles of $559.6 million for Q1 2026, down 4.26% year-over-year from $584.5 million in Q1 2025, and down 1.12% quarter-over-quarter from $566.0 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $559.6 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 4.26% year-over-year to $559.6 million; the TTM figure through Mar 2026 stood at $559.6 million (down 4.26% YoY), while the FY2025 annual figure was $566.0 million, down 4.18% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $559.6 million, down from $566.0 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $625.6 million in Q2 2023, with the low at $37.0 million in Q3 2022.
- The 5-year median for Goodwill & Intangibles is $578.5 million (2025), against an average of $429.4 million.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles fell 5.87% in 2022, then jumped 1572.25% in 2023.
- Amphastar Pharmaceuticals' Goodwill & Intangibles stood at $37.3 million in 2022, then surged by 1544.31% to $613.3 million in 2023, then retreated by 3.69% to $590.7 million in 2024, then retreated by 4.18% to $566.0 million in 2025, then dropped by 1.12% to $559.6 million in 2026.
- Business Quant data shows AMPH's Goodwill & Intangibles at $559.6 million in Q1 2026, $566.0 million in Q4 2025, and $572.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Amphastar Pharmaceuticals | 944.46 Mn | 654.33 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 647.83 Mn |
| Mar 31, 2026 | 559.62 Mn |
| Dec 31, 2025 | 565.97 Mn |
| Sep 30, 2025 | 572.24 Mn |
| Jun 30, 2025 | 578.50 Mn |
| Mar 31, 2025 | 584.53 Mn |
| Dec 31, 2024 | 590.66 Mn |
| Sep 30, 2024 | 594.80 Mn |
| Jun 30, 2024 | 600.85 Mn |
| Mar 31, 2024 | 607.06 Mn |
| Dec 31, 2023 | 613.30 Mn |
| Sep 30, 2023 | 619.35 Mn |
| Jun 30, 2023 | 625.60 Mn |
| Mar 31, 2023 | 37.18 Mn |
| Dec 31, 2022 | 37.30 Mn |
| Sep 30, 2022 | 37.04 Mn |
| Jun 30, 2022 | 37.70 Mn |
| Mar 31, 2022 | 38.44 Mn |
| Dec 31, 2021 | 38.87 Mn |
| Sep 30, 2021 | 39.19 Mn |